| EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach O Matzinger, E Gerber, Z Bernstein, P Maingon, K Haustermans, ... Radiotherapy and Oncology 92 (2), 164-175, 2009 | 157 | 2009 |
| Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer (EORTC trial 22922/10925) O Matzinger, I Heimsoth, P Poortmans, L Collette, H Struikmans, ... Acta Oncologica 49 (1), 24-34, 2010 | 131 | 2010 |
| Acute toxicity of curative radiotherapy for intermediate-and high-risk localised prostate cancer in the EORTC trial 22991 O Matzinger, F Duclos, A Van den Bergh, C Carrie, S Villà, P Kitsios, ... European journal of cancer 45 (16), 2825-2834, 2009 | 119 | 2009 |
| Interobserver variability in delineation of target volumes in head and neck cancer J van der Veen, A Gulyban, S Nuyts Radiotherapy and Oncology 137, 9-15, 2019 | 96 | 2019 |
| Quality assurance for prospective EORTC radiation oncology trials: the challenges of advanced technology in a multicenter international setting DC Weber, PMP Poortmans, CW Hurkmans, E Aird, A Gulyban, ... Radiotherapy and Oncology 100 (1), 150-156, 2011 | 94 | 2011 |
| Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review O Matzinger, P Poortmans, JY Giraud, P Maingon, T Budiharto, ... Radiotherapy and Oncology 90 (3), 285-290, 2009 | 61 | 2009 |
| Multisegmented tangential breast fields: a rational way to treat breast cancer A Gulyb n, Z Sebesty n, R Farkas, T Csere, G Kar csonyi, K D rczy, ... Strahlentherapie und Onkologie 184 (5), 262-269, 2008 | 57 | 2008 |
| Interobserver variability in organ at risk delineation in head and neck cancer J van der Veen, A Gulyban, S Willems, F Maes, S Nuyts Radiation Oncology 16, 1-11, 2021 | 49 | 2021 |
| Adaptive radiotherapy for locally advanced non-small cell lung cancer, can we predict when and for whom? P Berkovic, L Paelinck, Y Lievens, A Gulyban, B Goddeeris, C Derie, ... Acta Oncologica 54 (9), 1438-1444, 2015 | 49 | 2015 |
| Quality assurance in the EORTC 22033–26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review A Fairchild, DC Weber, R Bar-Deroma, A Gulyban, PA Fenton, R Stupp, ... Radiotherapy and Oncology 103 (3), 287-292, 2012 | 48 | 2012 |
| Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional … F Lakosi, M de Cuypere, P Viet Nguyen, N Jansen, B Warlimont, ... Acta oncologica 54 (9), 1558-1566, 2015 | 41 | 2015 |
| Improving generalization in MR‐to‐CT synthesis in radiotherapy by using an augmented cycle generative adversarial network with unpaired data KND Brou Boni, J Klein, A Gulyban, N Reynaert, D Pasquier Medical physics 48 (6), 3003-3010, 2021 | 37 | 2021 |
| Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial L Paelinck, A Gulyban, F Lakosi, T Vercauteren, W De Gersem, ... Radiotherapy and Oncology 122 (1), 30-36, 2017 | 37 | 2017 |
| Do results of the EORTC dummy run predict quality of radiotherapy delivered within multicentre clinical trials? A Fairchild, L Collette, CW Hurkmans, B Baumert, DC Weber, A Gulyban, ... European Journal of Cancer 48 (17), 3232-3239, 2012 | 36 | 2012 |
| EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility A Fairchild, E Aird, PA Fenton, V Gregoire, A Gulyban, D Lacombe, ... Radiotherapy and Oncology 103 (3), 279-286, 2012 | 36 | 2012 |
| Setup accuracy for prone and supine whole breast irradiation MD Thomas Mulliez, RN Annick van Greveling, BS RTT, ... Strahlentherapie und Onkologie 192 (4), 254, 2016 | 28 | 2016 |
| Dummy run and conformity indices in the ongoing EORTC low-grade glioma trial 22033-26033: first evaluation of quality of radiotherapy planning E Musat, E Roelofs, R Bar-Deroma, P Fenton, A Gulyban, L Collette, ... Radiotherapy and Oncology 95 (2), 218-224, 2010 | 26 | 2010 |
| A simple clinical method for predicting the benefit of prone vs. supine positioning in reducing heart exposure during left breast radiotherapy Z Kahán, F Rárosi, S Gaál, A Cserháti, K Boda, B Darázs, R Kószó, ... Radiotherapy and Oncology 126 (3), 487-492, 2018 | 23 | 2018 |
| EORTC Radiation Oncology & Breast Cancer Groups. Toxicity at three years with and without irradiation of the internal mammary and medial supraclavicular lymph node chain in … O Matzinger, I Heimsoth, P Poortmans, L Collette, H Struikmans, ... Acta Oncol 49 (1), 24-34, 2010 | 22 | 2010 |
| Respiratory Motion, Anterior Heart Displacement and Heart Dosimetry: Comparison Between Prone (Pr) and Supine (Su) Whole Breast Irradiation F Lakosi, A Gulyban, L Janvary, SBM Simoni, N Jansen, L Seidel, ... Pathology & Oncology Research 21, 1051-1058, 2015 | 21 | 2015 |
